These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 30747596)
1. Association between Periprocedural Neutropenia and Early Infection-related Chest Port Removal. Perez AW; Watchmaker JM; Brown DB; Banovac F Radiology; 2019 May; 291(2):513-518. PubMed ID: 30747596 [TBL] [Abstract][Full Text] [Related]
2. Severe Neutropenia at the Time of Implantable Subcutaneous Chest Port Insertion Is Not a Risk Factor for Port Removal at a Tertiary Pediatric Center. Hoss DR; Bedros AA; Mesipam A; Criddle J; Smith JC J Vasc Interv Radiol; 2017 Mar; 28(3):398-402. PubMed ID: 28034702 [TBL] [Abstract][Full Text] [Related]
3. Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients. Kakkos A; Bresson L; Hudry D; Cousin S; Lervat C; Bogart E; Meurant JP; El Bedoui S; Decanter G; Hannebicque K; Regis C; Hamdani A; Penel N; Tresch-Bruneel E; Narducci F Eur J Surg Oncol; 2017 Apr; 43(4):689-695. PubMed ID: 27889197 [TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Early Port Infections in Adult Oncologic Patients. Skummer P; Kobayashi K; DeRaddo JS; Blackburn T; Schoeneck M; Patel J; Jawed M J Vasc Interv Radiol; 2020 Sep; 31(9):1427-1436. PubMed ID: 32792279 [TBL] [Abstract][Full Text] [Related]
5. Central venous port implantations via the cephalic vein applying an intravasal electrographic control of the catheter tip position: a single-center experience of 316 cases. Schenck M; Schneider T; Rübben H; Eisenhardt A World J Urol; 2012 Jun; 30(3):399-404. PubMed ID: 21874511 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy. Hong S; Seo TS; Song MG; Seol HY; Suh SI; Ryoo IS J Vasc Access; 2019 Mar; 20(2):134-139. PubMed ID: 29923460 [TBL] [Abstract][Full Text] [Related]
7. Neutropenia at the time of subcutaneous port insertion may not be a risk factor for early infectious complications in pediatric oncology patients. VanHouwelingen LT; Veras LV; Lu M; Wynn L; Wu J; Prajapati HJ; Gold RE; Murphy AJ; Fernandez-Pineda I; Gosain A; Pui CH; Davidoff AM J Pediatr Surg; 2019 Jan; 54(1):145-149. PubMed ID: 30661598 [TBL] [Abstract][Full Text] [Related]
8. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT). Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J Trials; 2018 May; 19(1):264. PubMed ID: 29720244 [TBL] [Abstract][Full Text] [Related]
9. Late complications associated with totally implantable venous access port implantation via the internal jugular vein. Tsuruta S; Goto Y; Miyake H; Nagai H; Yoshioka Y; Yuasa N; Takamizawa J Support Care Cancer; 2020 Jun; 28(6):2761-2768. PubMed ID: 31724073 [TBL] [Abstract][Full Text] [Related]
10. Does systemic antibiotic prophylaxis prior to the placement of totally implantable venous access devices reduce early infection? A retrospective study of 1,485 cases at a large academic institution. Choksi A; Finnegan K; Etezadi V Am J Infect Control; 2020 Jan; 48(1):95-99. PubMed ID: 31439370 [TBL] [Abstract][Full Text] [Related]
11. Polyurethane versus silicone catheters for central venous port devices implanted at the forearm. Wildgruber M; Lueg C; Borgmeyer S; Karimov I; Braun U; Kiechle M; Meier R; Koehler M; Ettl J; Berger H Eur J Cancer; 2016 May; 59():113-124. PubMed ID: 27023050 [TBL] [Abstract][Full Text] [Related]
12. Length of Stay Predicts Risk of Early Infection for Hospitalized Patients Undergoing Central Venous Port Placement. Tang L; Kim CY; Martin JG; Pabon-Ramos WM; Sag AA; Suhocki PV; Smith TP; Ronald J J Vasc Interv Radiol; 2020 Mar; 31(3):454-461. PubMed ID: 32007408 [TBL] [Abstract][Full Text] [Related]
13. Radiologic placement of a low profile implantable venous access port in a pediatric population. Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746 [TBL] [Abstract][Full Text] [Related]
14. Image-guided placement of port catheters: is there an increased risk of infection if the port is immediately accessed and used? Salazar G; Yeddula K; Wicky S; Oklu R; Ganguli S; Waltman AC; Walker TG; Kalva SP J Vasc Access; 2013; 14(2):170-4. PubMed ID: 23080333 [TBL] [Abstract][Full Text] [Related]
15. Exclusion of neutropenic children from implanted central venous catheter placement: impact on early catheter removal. Gutierrez I; Gollin G J Pediatr Surg; 2010 Jun; 45(6):1115-9. PubMed ID: 20620305 [TBL] [Abstract][Full Text] [Related]
16. Clinical predictors of port infections within the first 30 days of placement. Bamba R; Lorenz JM; Lale AJ; Funaki BS; Zangan SM J Vasc Interv Radiol; 2014 Mar; 25(3):419-23. PubMed ID: 24581465 [TBL] [Abstract][Full Text] [Related]
17. Outpatient placement of subcutaneous venous access ports reduces the rate of infection and dehiscence compared with inpatient placement. Pandey N; Chittams JL; Trerotola SO J Vasc Interv Radiol; 2013 Jun; 24(6):849-54. PubMed ID: 23582442 [TBL] [Abstract][Full Text] [Related]
18. Management of Port Occlusions in Adults: Different-Site Replacement versus Same-Site Salvage. Pabon-Ramos WM; Soyinka O; Smith TP; Ronald J; Suhocki PV; Kim CY J Vasc Interv Radiol; 2019 Jul; 30(7):1069-1074. PubMed ID: 31133452 [TBL] [Abstract][Full Text] [Related]
19. Impact of severe neutropenia and other risk factors on early removal of implanted central venous catheter (ICVC) in children with hematologic malignancies. Cesca E; Dall'igna P; Boscolo-Berto R; Meneghini L; Petris MG; Zanon GF; Cecchetto G J Pediatr Hematol Oncol; 2014 Oct; 36(7):541-4. PubMed ID: 24714504 [TBL] [Abstract][Full Text] [Related]
20. Central line bundle for prevention of central line-associated bloodstream infection for totally implantable venous access devices (ports) in pediatric cancer patients. Devrim İ; Oruç Y; Demirağ B; Kara A; Düzgöl M; Uslu S; Yaşar N; Aydın Köker S; Töret E; Bayram N; Vergin C J Vasc Access; 2018 Jul; 19(4):358-365. PubMed ID: 29926785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]